Worth Financial Advisory Group’s AbbVie ABBV Stock Holding History

Worth Financial Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$827K	Buy	3,287 +867	+36%	+$187K	0.34%	76
2026 Q1	$19.7M	Sell	2,420 -546	-18%	-$121K	8.59%	4
2025 Q4	$678K	Sell	2,966 -32	-1%	-$7.29K	0.33%	74
2025 Q3	$694K	Sell	2,998 -41	-1%	-$8.35K	0.39%	64
2025 Q2	$564K	Buy	3,039 +33	+1%	+$6.13K	0.35%	69
2025 Q1	$630K	Sell	3,006 -130	-4%	-$25.3K	0.4%	65
2024 Q4	$557K	Sell	3,136 -144	-4%	-$26.5K	0.34%	72
2024 Q3	$648K	Buy	3,280 +153	+5%	+$28.6K	0.38%	66
2024 Q2	$536K	Sell	3,127 -219	-7%	-$36.3K	0.35%	72
2024 Q1	$609K	Sell	3,346 -23	-0.7%	-$3.96K	0.42%	64
2023 Q4	$522K	Sell	3,369 -217	-6%	-$31.6K	0.42%	67
2023 Q3	$535K	Sell	3,586 -2,376	-40%	-$349K	0.48%	56
2023 Q2	$803K	Buy	5,962 +33	+0.6%	+$4.84K	0.75%	35
2023 Q1	$945K	Buy	5,929 +3,823	+182%	+$584K	0.9%	25
2022 Q4	$340K	Buy	+2,106	New	+$323K	0.4%	69

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Worth Financial Advisory Group's ABBV Position: Q2 2026 in Review

Worth Financial Advisory Group increased its AbbVie (ABBV) stake by 36% in Q2 2026, buying an estimated $187K and bringing the position to 3,287 shares worth $827K. The position accounts for 0.34% of the portfolio, ranked #76.

Worth Financial Advisory Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $19.7M in Q1 2026. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Worth Financial Advisory Group held 3,287 shares of AbbVie worth $827K as of Q2 2026.
Worth Financial Advisory Group bought 867 AbbVie shares in Q2 2026, an estimated $187K.
AbbVie made up 0.34% of Worth Financial Advisory Group's portfolio in Q2 2026, its #76 holding.
Worth Financial Advisory Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
Worth Financial Advisory Group's AbbVie position peaked at $19.7M in Q1 2026.
4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Worth Financial Advisory Group's 13F filing for Q2 2026, filed 31 Jul 2026.